Home » DISCOVERY LABS SAYS IT IS MAKING HEADWAY ON NEW DRUG
DISCOVERY LABS SAYS IT IS MAKING HEADWAY ON NEW DRUG
Discovery Laboratories Inc. said Tuesday it is making progress on its ongoing investigation into, and remediation efforts for, a problem that has delayed the approval of its lead new drug candidate Surfaxin.
Philadelphia
Business Journal
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May